What We're Reading: Page 82
Industry reads hand-picked by our editors
Jul 19, 2023
-
Bloomberg
Eyedrop Recall 2023 and Infections Were Result of Lack of FDA Regulation
-
The Wall Street Journal
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
-
Nature
Medicine is plagued by untrustworthy clinical trials. How many studies are faked or flawed?
-
Harper’s Magazine
Love in the Time of Sickle Cell Disease
Jul 18, 2023
-
The Washington Post
As pandemic raged, global south lacked vaccines. Never again, researchers vow.
-
Axios
Medicare proposes broader coverage of PET scans for Alzheimer’s patients
-
Fierce Pharma
Mirum ponies up $435M for 2 Travere liver disease drugs
-
The New York Times
Evelyn M. Witkin, Who Discovered How DNA Repairs Itself, Dies at 102
Jul 17, 2023
Jul 14, 2023
-
The Wall Street Journal
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
-
Axios
Cost could limit demand for over-the-counter birth control pills
-
Evaluate Vantage
Acadia pays $100m to double up in Rett
Previous
